Imaprelimab

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameImaprelimab
Drug Alias NamePRX-003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionMelanoma cell adhesion molecule inhibitors
TargetsMelanoma cell adhesion molecule
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNeotope BiosciencesOnclave Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProthena Biosciences Ltd
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A